izpis_h1_title_alt

Cold atmospheric plasma for surface disinfection : a promising weapon against deleterious meticillin-resistant Staphylococcus aureus biofilms
ID Lunder, Manca (Avtor), ID Dahle, Sebastian (Avtor), ID Fink, Rok (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (3,38 MB)
MD5: 7471C74B06EB1BDD5A40431FE0CA62C1
URLURL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S0195670123003493 Povezava se odpre v novem oknu

Izvleček
Background: Bacteria are becoming increasingly resistant to classical antimicrobial agents, so new approaches need to be explored. Aim: To assess the potential of cold atmospheric plasma for the management of methicillin-resistant Staphylococcus aureus (MRSA). Methods: The 24, 48, and 72 h resistant and susceptible S. aureus biofilms were exposed to 60, 120, and 180 s treatment with plasma. Findings: Increasing the treatment time results in higher cell reduction for both susceptible and resistant strains of S. aureus (P < 0.05). Up to log$_{10}$ reduction factor of 5.24 cfu/cm$^2$ can be achieved in 180 s of plasma treatment. Furthermore, plasma can substantially alter the cell’s metabolisms and impact cell membrane integrity. However, it has not been shown that plasma can reduce biofilm biomass in the case of 24 h and 48 h biofilms, although the 72 h biofilm was more susceptible, and its biomass was decreased (P < 0.05). The accumulation of intrabacterial reactive oxygen species was also observed, which confirms the plasma’s induction of oxidative stress. Finally, it was shown that continuous plasma exposure of bacterial cells does not cause resistance to plasma, nor is resistance developed to cefoxitin. Conclusion: Cold atmospheric plasma is a good candidate for S. aureus and MRSA biofilm treatment and may therefore be of value in the bacterial resistance crisis.

Jezik:Angleški jezik
Ključne besede:cold atmospheric plasma, Staphylococcus aureus, MRSA, reduction, metabolic activity, resistance
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:ZF - Zdravstvena fakulteta
BF - Biotehniška fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:Str. 64-75
Številčenje:Vol. 143
PID:20.500.12556/RUL-152544 Povezava se odpre v novem oknu
UDK:616.9:614
ISSN pri članku:0195-6701
DOI:10.1016/j.jhin.2023.10.014 Povezava se odpre v novem oknu
COBISS.SI-ID:173756675 Povezava se odpre v novem oknu
Datum objave v RUL:27.11.2023
Število ogledov:966
Število prenosov:668
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:The journal of hospital infection
Skrajšan naslov:J. hosp. infect.
Založnik:Elsevier, The Healthcare Infection Society
ISSN:0195-6701
COBISS.SI-ID:6404871 Povezava se odpre v novem oknu

Licence

Licenca:CC BY-NC-ND 4.0, Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc-nd/4.0/deed.sl
Opis:Najbolj omejujoča licenca Creative Commons. Uporabniki lahko prenesejo in delijo delo v nekomercialne namene in ga ne smejo uporabiti za nobene druge namene.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:hladna atmosferska plazma, Staphylococcus aureus, MRSA, zmanjšanje, presnovna aktivnost, odpornost

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P4-0015
Naslov:Les in lignocelulozni kompoziti

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj